4//SEC Filing
HENNEY CHRISTOPHER S 4
Accession 0001104659-22-071893
CIK 0001130166other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:11 PM ET
Size
7.2 KB
Accession
0001104659-22-071893
Insider Transaction Report
Form 4
HENNEY CHRISTOPHER S
Director
Transactions
- Award
Common Stock
2022-06-14+15,822→ 18,196 total - Award
Stock Option (right to buy)
2022-06-14+31,645→ 31,645 totalExercise: $1.11From: 2023-06-14Exp: 2032-06-14→ Common Stock (31,645 underlying)
Footnotes (2)
- [F1]The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023.
- [F2]These options were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001242880
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:11 PM ET
- Size
- 7.2 KB